BioSpace Movers & Shakers, Jan. 1
The Pharma Data
DECEMBER 31, 2020
Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
Let's personalize your content